Esophageal Cancer

Showing 101 - 125 of 805

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Esophageal Cancer, Metastatic Cancer, Squamous Cell Carcinoma Trial in Taipei City (Cabozantinib 40 MG, Atezolizumab Injection)

Recruiting
  • Esophageal Cancer
  • +2 more
  • Cabozantinib 40 MG
  • Atezolizumab Injection
  • Taipei City, Taiwan
    National Taiwan University Hospital
Sep 15, 2022

Esophageal Cancer Trial in Beijing (3DCRT)

Recruiting
  • Esophageal Cancer
  • 3DCRT
  • Beijing, Beijing, China
    Department of Radiation Oncology, National Cancer Center/Nationa
Sep 13, 2022

Esophageal Cancer Trial (cushion)

Not yet recruiting
  • Esophageal Cancer
  • cushion
  • (no location specified)
Sep 13, 2022

Gastric Cancer, Gastroesophageal-junction Cancer, Esophageal Cancer Trial (LB1908)

Not yet recruiting
  • Gastric Cancer
  • +3 more
  • LB1908
  • (no location specified)
Sep 9, 2022

Gastric Cancer, Colon Cancer, Rectal Cancer Trial in Henan (CEA-targeted CAR-T cells)

Recruiting
  • Gastric Cancer
  • +4 more
  • CEA-targeted CAR-T cells
  • Henan, China
    He'nan Cancer Hospital
Sep 9, 2022

Hypoxia, Gastric Cancer, Gastric Polyp Trial in Zhengzhou, Shanghai, Kunming (nasal mask oxygen kit, regular nasal cannula)

Recruiting
  • Hypoxia
  • +5 more
  • nasal mask oxygen kit
  • regular nasal cannula
  • Zhengzhou, Henan, China
  • +2 more
Sep 6, 2022

Dysphagia, Esophageal, Esophageal Cancer Trial in Morgantown (Suture fixation of stent, Non suture)

Recruiting
  • Dysphagia, Esophageal
  • Esophageal Cancer
  • Suture fixation of stent
  • Non suture
  • Morgantown, West Virginia
    West Virginia University
Aug 27, 2022

Biomarkers in Subjects With Untreated Solid Tumors

Completed
  • Breast Cancer
  • +12 more
  • Blood Sample Collection
  • Phoenix, Arizona
  • +118 more
Aug 31, 2022

Nutrition Intervention Trials in Linxian Follow-up Study

Enrolling by invitation
  • Esophageal Cancer
  • Gastric Cancer
    • Beijing, China
      Cancer Institute and hospital, Chinese Academy of Medical Scienc
    Aug 24, 2022

    Esophageal Cancer, Esophagogastric Junction Cancer Trial in Worldwide (Autologous genetically modified ADP-A2M4CD8 cells)

    Recruiting
    • Esophageal Cancer
    • Esophagogastric Junction Cancer
    • Autologous genetically modified ADP-A2M4CD8 cells
    • Duarte, California
    • +33 more
    Aug 23, 2022

    Melanoma, Non-small Cell Lung Carcinoma (NSCLC), Renal Cell Carcinoma (RCC) Trial in Gainesville, Jacksonville (LITT +

    Recruiting
    • Melanoma
    • +14 more
    • LITT + Pembrolizumab
    • Gainesville, Florida
    • +1 more
    Aug 22, 2022

    Cervical Cancer, Endometrial Cancer, Esophageal Cancer Trial run by the National Cancer Institute (NCI) (HDR Brachytherapy)

    Recruiting
    • Cervical Cancer
    • +4 more
    • HDR Brachytherapy
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 19, 2022

    Advanced Solid Cancer, Non Small Cell Lung Cancer, Esophageal Cancer Trial in China (APG-2449)

    Recruiting
    • Advanced Solid Cancer
    • +4 more
    • Beijing, Beijing, China
    • +9 more
    Aug 17, 2022

    Esophageal Cancer in Northeastern Iran

    Active, not recruiting
    • Esophageal Cancer
    • GI Disease
      • Tehran, Iran, Islamic Republic of
        Digestive Disease Research Institute
      Aug 18, 2022

      Ovarian Cancer, Ovarian Tumors, Ovarian Carcinoma Trial in United States (ELU001)

      Recruiting
      • Ovarian Cancer
      • +68 more
      • Phoenix, Arizona
      • +8 more
      Aug 18, 2022

      Mesothelioma, Glioblastoma, Renal Cell Carcinoma Trial in Korea, Republic of, Taiwan, United States (NGM707, NGM707 plus

      Recruiting
      • Mesothelioma
      • +14 more
      • Los Angeles, California
      • +13 more
      Aug 16, 2022

      Pancreatic Ductal Adenocarcinoma, Colorectal Cancer, Esophageal Cancer Trial in Toronto ([Ga-68]-PNT6555, [Lu-177]-PNT6555)

      Recruiting
      • Pancreatic Ductal Adenocarcinoma
      • +4 more
      • Toronto, Ontario, Canada
        University Health Network - Princess Margaret Cancer Centre
      Aug 16, 2022

      Esophageal Cancer, Perioperative Analgesia, NSAIDs Trial in Beijing (Preemptive flurbiprofen axetil, Postoperative flurbiprofen

      Not yet recruiting
      • Esophageal Cancer
      • +4 more
      • Preemptive flurbiprofen axetil
      • +2 more
      • Beijing, China
        Cancer Hospital Chinese Academy of Medical Sciences
      Aug 15, 2022

      Esophageal Cancer, Gastric Cancer Trial in Stockholm (Octreotide Injection)

      Recruiting
      • Esophageal Cancer
      • Gastric Cancer
      • Octreotide Injection
      • Stockholm, Sweden
        Karolinska University Hospital, Huddinge
      Aug 16, 2022

      The Microbiome of Oesophageal Squamous Cell Carcinoma

      Recruiting
      • Esophageal Cancer
      • Microbial Colonization
      • Upper endoscopy
      • Hong Kong, Hong Kong
        Prince of Wales Hospital
      Aug 15, 2022

      Colorectal Cancer, Pancreatic Cancer, Esophageal Cancer Trial in Boston (LUM015, LUM 2.6 Imaging Device)

      Recruiting
      • Colorectal Cancer
      • +3 more
      • Boston, Massachusetts
        Massachusetts General Hospital
      Aug 15, 2022

      Cancer, Solid Tumor, Solid Carcinoma Trial in Houston (AMXT1501, DFMO)

      Recruiting
      • Cancer
      • +18 more
      • Houston, Texas
        MD Anderson Cancer Center
      Aug 12, 2022

      Adjuvant Radiotherapy for pT1b Esophageal Cancer After

      Completed
      • Esophageal Cancer
        • Beijing, China
          National Cancer Center/Cancer Hospital, Chinese Academy of Medic
        Aug 10, 2022

        Advanced Solid Tumor, Metastatic Cancer, Refractory Cancer Trial in Huntersville, Houston, Webster (PT199, Anti-PD-1 mAb)

        Recruiting
        • Advanced Solid Tumor
        • +18 more
        • PT199
        • Anti-PD-1 monoclonal antibody
        • Huntersville, North Carolina
        • +2 more
        Aug 10, 2022

        Esophageal Cancer Associated Neoantigens

        Not yet recruiting
        • Esophageal Cancer
        • Neoantigen
        • ratio of predicted neoantigens
        • Ho Chi Minh City, Vietnam
          University Medical Center Ho Chi Minh City
        Aug 9, 2022